Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Oral Dis ; 9(6): 279-83, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14629326

ABSTRACT

AIM: Eotaxin is a powerful and selective eosinophil chemoattractant. The purpose of this study was to compare the expression of eotaxin in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia (TATE). The mechanisms that control the recruitment of eosinophils to these tumours are not clearly established. METHODS: A total of 60 patients with oral squamous cell carcinomas (OSCC) with TNM stages II and III, located in the tongue, oral floor, retromolar area and inferior gingiva were divided in two groups: 1--OSCC with intense eosinophilic inflammatory infiltrate and 2--OSCC with absent/low eosinophilic inflammatory infiltrate. The eotaxin expression was analyzed by immunohistochemistry using standard streptavidin-biotin-peroxidase complex technique with monoclonal (mouse anti-human eotaxin) and polyclonal (rabbit anti-human eotaxin) antibodies. RESULTS: The eotaxin expression was identified in normal oral mucosa as well as in both OSCC groups including malignant epithelial cells, eosinophils, neutrophils, plasma cells and fibroblasts. The eosinophils showed intense immunopositivity for eotaxin. CONCLUSION: These results suggest that the eotaxin expressed in oral squamous cell carcinomas, mainly derived from eosinophils, is probably involved in the mechanisms of eosinophils chemotaxis to the tumour and in the maintenance of TATE in these malignant tumours.


Subject(s)
Carcinoma, Squamous Cell/pathology , Chemokines, CC/analysis , Chemotactic Factors, Eosinophil/analysis , Eosinophilia/pathology , Mouth Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Chemokine CCL11 , Chemotaxis, Leukocyte/physiology , Eosinophils/pathology , Epithelial Cells/pathology , Female , Fibroblasts/pathology , Humans , Male , Middle Aged , Neoplasm Staging , Neutrophils/pathology , Plasma Cells/pathology
2.
Histol Histopathol ; 18(3): 709-13, 2003 07.
Article in English | MEDLINE | ID: mdl-12792882

ABSTRACT

In a previous study, we found tumor-associated tissue eosinophilia (TATE) to be a favourable prognostic indicator for oral squamous cell carcinomas. Special techniques such as autofluorescence or immunohistochemistry are reported to be sometimes necessary to detect the presence of intact and degranulating eosinophils within the tumors. The aim of this study was to compare the number of eosinophils identified routinely with hematoxylin and eosin stain and by immunohistochemistry in oral squamous cell carcinomas with TATE. Thirty specimens of oral squamous cell carcinoma of the tongue, floor of the mouth, retromolar area and inferior gingiva with TNM stages II and III were used for histopathological analysis. Three-micrometer sections were stained with hematoxylin and eosin and immunohistochemically with monoclonal anti-human granulocyte-associated antigen using a standard streptavidin-biotin-peroxidase complex technique. The number of eosinophils/mm2 in the invasive front of the tumors was automatically quantified in a x400 field using an image computer analyser. Univariate statistical analysis was carried out using Student's t test. The computer-assisted morphometric results showed that there was no statistically significant difference (p>0.05) in the number of eosinophils/mm2 identified by hematoxylin and eosin or immunostaining technique in oral squamous cell carcinomas with TATE. This result suggests that hematoxilyn and eosin routine stain is a useful technique for measuring eosinophils in squamous cell carcinoma with eosinophilic tumor infiltration.


Subject(s)
Carcinoma, Squamous Cell/complications , Eosinophilia/pathology , Mouth Neoplasms/complications , Aged , Carcinoma, Squamous Cell/pathology , Eosinophilia/diagnosis , Eosinophils/metabolism , Female , Humans , Immunohistochemistry , Lewis X Antigen/biosynthesis , Male , Middle Aged , Mouth Neoplasms/pathology
3.
Histopathology ; 41(2): 152-7, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12147093

ABSTRACT

AIMS: Tumour-associated tissue eosinophilia has been described in many sites, including head and neck. The mechanism of eosinophil recruitment and its role in tumours has not yet been defined, and its presence has been related to a favourable as well as unfavourable prognosis. The aim of this study was to evaluate the influence of tumour-associated tissue eosinophilia on the prognosis of 125 oral squamous cell carcinoma patients. METHODS AND RESULTS: The number of eosinophils was obtained by morphometric analysis and ranged from 0 to 392 per mm2. Tumour-associated tissue eosinophilia was classified according to intensity as mild, moderate, or intense and correlated statistically to the intensity of the mononuclear inflammatory infiltrate as well as to the location of the eosinophilic inflammatory infiltrate. The multivariate analysis demonstrated that intense tumour-associated tissue eosinophilia is an independent favourable prognostic factor for oral squamous cell carcinomas. CONCLUSION: These findings suggest an anti-tumoral role of eosinophils not as yet well understood that should be better investigated.


Subject(s)
Carcinoma, Squamous Cell/pathology , Eosinophilia/pathology , Mouth Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local , Neoplasms, Second Primary , Prognosis , Recurrence , Sex Factors
4.
Braz Dent J ; 12(1): 63-6, 2001.
Article in English | MEDLINE | ID: mdl-11210255

ABSTRACT

A case of gingival erosive lichen planus is presented with special emphasis on its clinical and microscopic characteristics. The differential diagnosis and the controversy associated with the malignant potential of oral lichen planus is also discussed.


Subject(s)
Gingival Diseases/diagnosis , Lichen Planus, Oral/diagnosis , Adult , Anti-Inflammatory Agents/therapeutic use , Biopsy , Epithelium/pathology , Erythema/diagnosis , Female , Glucocorticoids/therapeutic use , Humans , Triamcinolone Acetonide/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...